You may have seen the recent announcement: CMS has proposed dramatic changes to how Medicare pays for Remote Patient Monitoring (RPM) and Remote Therapeutic Monitoring (RTM) services, and it has received significant trade-press attention this past few weeks. Whether your pharmacy is already running a Medsense program, or you are in the decision phase, we want to be clear: these proposed changes wouldn’t require any modifications to how we are currently running your program. In fact, the proposed rule changes offer a clear explanation of how a compliant program should work.
Every July, CMS proposes routine updates to these rules. This year’s changes target operators who outsource clinical oversight to a third party, or skip steps toward establishing a patient relationship. Creating a compliant RPM/RTM program takes years, and industry coverage has already noted that many vendors in this space would not be able to bring that work in-house before the Jan. 1, 2027 effective date, should these proposed rule changes be adopted.
To help pharmacy owners understand these proposed changes, and how they apply with respect to Medsense programs, we have developed a concise position paper. After you've had a chance to review, or if you have questions about your specific account, feel free to reach out to your Medsense team directly.